OPK Financial Facts

Research and development: 24.42M
Product sales: 20.57M
See Full Income Statement

Inventory, net: 43.19M
Long-term liabilities: 440.12M
See Full Balance Sheet

Opko Health (OPK) Earnings

  |   Expand Research on OPK
Next EPS Date N/A EPS Growth Rate -120.0% *Last Qtr.
Average EPS % Beat Rate -28.3% Revenue Growth Rate -8.4% *Last Qtr.
Average % Move 1-Wk after EPS -8.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/5/19 Q319 -$0.11-$0.09 -$0.02$228.8M$225.4M N/A Details
8/7/19 Q219 -$0.10-$0.11 +$0.01$226.4M$225.57M N/A Details
5/7/19 Q119 -$0.14-$0.09 -$0.05$222.5M$241.27M N/A Details
2/27/19 Q418 -$0.13-$0.09 -$0.04$221.9M$245.3M N/A Details
11/9/18 Q318 -$0.05-$0.08 +$0.03$249.8M$264.04M N/A Details
8/7/18 Q218 -$0.01-$0.07 +$0.06$263.7M$261.65M N/A Details
5/8/18 Q118 -$0.08-$0.13 +$0.05$254.9M$236.9M N/A Details
3/1/18 Q417 -$0.38-$0.08 -$0.30$193.7M$301.4M = Details